Literature DB >> 12789102

Comparison of immunohistochemical and modified Giemsa stains for demonstration of Helicobacter pylori infection in an African population.

H R Wabinga1.   

Abstract

BACKGROUND: Modified Giemsa staining has been favoured by many researchers because it is easy to perform but, like many other stains, demonstration of the bacteria depends on its morphology. It has been arged in some research circles that some of the organisms in the gastric mucosa may not be true H.pylori. Immunohistochemical techniques have been developed and make use of anti H.pylori antibody, which reacts, with somatic antigens of the whole bacteria and have been found to correlate well with the presence of the bacteria.
OBJECTIVE: To ascertain the efficacy of modified Giemsa stain in an African setting where H.Pylori seems quite prevalent. STUDY
DESIGN: A laboratory-based study of two diagnostic tests in which modified Giema stain was compared with immunohistochemistry.
METHODS: A total of 48 consecutive autopsy cases with no upper gastro intestinal diseases had their gastric mucosa stained for demonstration of H.pylori using both modified Giemsa and immunohisto chemical staining techniques.
RESULTS: Twenty-seven cases of H.pylori were demonstrated by both techniques and 14 cases were not identified by the two staining methods. In 2 cases immunostain could not demonstrate the bacteria but they were identified with modified Giemsa stain while in 5 cases the bacteria were identified by immunostain but not with modified Giemsa stain. The sensitivity of modified Giemsa stain was 85% (CI 66.5-98.8) while the specificity was 89% (CI 60.4 - 97.8). The positive predictive value of modified Giemsa stain was 93% CI 75 - 98.8%) while the negative predictive value was 74% (CI 48.6 - 89.9). The kappa statistic comparing the 2 stains was 0.69 (p value 0.00001) giving a good agreement between the two tests.
CONCLUSION: With the above results the modified Giemsa stain, which is readily available in most African laboratories, is recommenced for diagnosis of H.pylori, a prevalent infection in Africa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12789102      PMCID: PMC2141568     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  8 in total

Review 1.  Helicobacter pylori and duodenal ulcer. Evidence suggesting causation.

Authors:  F Mégraud; H Lamouliatte
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

2.  Simplified techniques for identifying Campylobacter pyloridis.

Authors:  S F Gray; J I Wyatt; B J Rathbone
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

3.  Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

Authors:  C P Dooley; H Cohen; P L Fitzgibbons; M Bauer; M D Appleman; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1989-12-07       Impact factor: 91.245

Review 4.  Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence.

Authors:  N Muñoz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jul-Aug       Impact factor: 4.254

5.  Coccoid like forms (CLF) of Helicobacter pylori. Enzyme activity and antigenicity.

Authors:  M Nilius; A Ströhle; G Bode; P Malfertheiner
Journal:  Zentralbl Bakteriol       Date:  1993-09

6.  Evaluation of staining methods for identifying Campylobacter pylori.

Authors:  E Madan; J Kemp; T U Westblom; M Subik; S Sexton; J Cook
Journal:  Am J Clin Pathol       Date:  1988-10       Impact factor: 2.493

7.  Campylobacter pylori detected by indirect immunohistochemical technique.

Authors:  L P Andersen; S Holck; C O Povlsen
Journal:  APMIS       Date:  1988-06       Impact factor: 3.205

8.  Helicobacter pylori in gastric biopsies--should you trust the pathology report?

Authors:  A J Molyneux; M D Harris
Journal:  J R Coll Physicians Lond       Date:  1993-04
  8 in total
  5 in total

1.  Helicobacter pylori in Cholecystectomy Specimens-Morphological and Immunohistochemical Assessment.

Authors:  Rashmi Patnayak; Venkatarami Reddy; Amitabh Jena; Siva Gavini; Asha Thota; Rukamangadha Nandyala; Amit Kumar Chowhan
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  The immunohistochemistry and toluidine blue roles for Helicobacter pylori detection in patients with gastritis.

Authors:  Raziye Tajalli; Maliheh Nobakht; Hajar Mohammadi-Barzelighi; Shahram Agah; Abdolaziz Rastegar-Lari; Alireza Sadeghipour
Journal:  Iran Biomed J       Date:  2013

3.  Restriction fragment length polymorphism of adhesin gene hpaA from different Helicobacter pylori strains of Chongqing, China.

Authors:  Yu Hong; Xu-Hu Mao; Wei-Kun Zeng; Li-Ming Ma; Shen-Rong Jing; Quan-Ming Zou
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

4.  Effect of Helicobacter pylori on NFKB1, p38α and TNF-α mRNA expression levels in human gastric mucosa.

Authors:  Henrique Sulzbach Sulzbach DE Oliveira; Vanderlei Biolchi; Helouise Richardt Richardt Medeiros; Daiane Bizerra Gandor Bizerra Gandor Jantsch; Luciana Knabben Knabben DE Oliveira Becker Delving; Roberto Reckziegel; Márcia Inês Goettert; Ilma Simoni Brum; Adriane Pozzobon
Journal:  Exp Ther Med       Date:  2016-03-31       Impact factor: 2.447

5.  Helicobacter pylori may be an initiating factor in newly diagnosed ulcerative colitis patients: A pilot study.

Authors:  Loai Mansour; Ferial El-Kalla; Abdelrahman Kobtan; Sherief Abd-Elsalam; Mohamed Yousef; Samah Soliman; Lobna Abo Ali; Walaa Elkhalawany; Ibrahim Amer; Heba Harras; Maha M Hagras; Mohamed Elhendawy
Journal:  World J Clin Cases       Date:  2018-11-06       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.